Background & Aims: In the intestine the canonical Wnt signaling cascade plays a crucial role in driving proliferation of epithelial cells. Furthermore, aberrant activation of Wnt signaling is strongly associated with the development of colorectal cancer. Despite this evidence, little is known about the precise identity and localization of Wnts and their downstream effectors in the adult intestine. To address this issue we examined the expression pattern of all Wnts, Fzs, LRPs, Wnt antagonists and TCFs in the murine small intestine, colon and adenomas. Methods: Embryonic, postnatal and adult intestinal samples were subjected to in situ hybridisation using specific RNA probes for the various genes tested. Results: Our analysis revealed high expression of several signaling components (including Wnt-3, in crypt epithelial cells. We also detected Wnt2b, in differentiated epithelial and/or mesenchymal cells of the small intestine and colon. Finally, several factors LEF, displayed differential expression in normal versus neoplastic tissue. Conclusion: Our study predicts a much broader role for Wnt signaling in gut development and homeostasis than was previously anticipated from available genetic studies and identifies novel factors likely involved in promoting canonical, as well as non-canonical Wnt signals in the intestine.
Introduction
The intestine harbors a variety of cell types, organized into highly regular structures, known as villi and crypts of Lieberkühn. The absorptive and protective functions of the gut are ensured by enterocytes, goblet cells, Paneth cells and enteroendocrine cells. These differentiated epithelial cells arise from transit amplifying progenitors and ultimately stem cells, both of which reside in the crypts. The intestine also consists of a layer of loose connective tissue or mesenchyme, which is thought to provide structural support and growth signals to the overlying epithelium. Finally, embedded within the various layers of the intestine, one additionally finds blood vessels, smooth muscle and neuronal cells, as well as lymphocytes.
Cellular proliferation and differentiation in the intestine depends on a large array of signaling molecules (104;208) . One such example includes the Wnt family of secreted growth factors (13;209;210) . Wnts are evolutionarily conserved, cysteine-rich glycoproteins, capable of signaling in both paracrine and autocrine fashion. Wnts induce a wide range of biological effects by binding to the seven-span transmembrane protein, Frizzled (Fz) (20) and the single-span LDL receptor-related protein, . In a complex with Fz/LRP, Wnts trigger the release of β-catenin from a so-called destruction complex, which in the absence of Wnts, promotes ubiquitin-mediated degradation of β-catenin (209). Subsequently, free β-catenin shuttles to the nucleus where it associates with DNA binding factors of the TCF (Tcell factor) family in order to activate transcription of target genes (39;40). More recent evidence has shown that Wnts may also stimulate cellular responses, independently of β-catenin and TCF (25;211). Examples of these so-called non-canonical pathways involve either the intracellular release of calcium ions and activation of Ca ++ dependent kinases or morphogenic changes dependent on RhoA and Jun kinase stimulation, also termed the planar cell polarity pathway.
Genetic studies have demonstrated an essential role for canonical Wnt signaling in regulating intestinal epithelial cell proliferation. One of the earliest indications of this came from the analysis of mutations in core Wnt signaling components such as APC and β-catenin (212-214). These genetic alterations lead to the formation of intestinal adenomas, as a result of deregulated nuclear accumulation of β-catenin and constitutive activation of target genes associated with proliferation of epithelial cells (73;215-217) . Conversely, blockage of canonical Wnt signals in the intestine, either through deletion of TCF-4 or overexpression of the Wnt antagonist, Dkk-1, results in arrested epithelial cell proliferation (66-68). Another function ascribed to Wnt signaling in epithelial cells was recently uncovered through DNA micro-array analysis. EphB2 and B3 are TCF-4-responsive genes, which regulate upward movement of epithelial cells and the positioning of Paneth cells within the crypt-villus axis (86). Together these data provide clear evidence that proliferation, as well as sorting of crypt epithelial cells depends on the correct dosage of canonical Wnt signals. Despite the functional evidence described above, relatively little is known about the localization of Wnt signaling components within the intestine. Expression studies in mice and chicks have shown that during embryonic development Wnt gene products are broadly expressed throughout the intestinal tract (203;218;219) . In the adult intestine Wnt expression is maintained (220) but their precise localization remains unclear. To address this issue in detail, we screened the expression patterns of all known Wnts, Fz/LRP and Wnt antagonists, as well as TCF family members in the adult intestine by in situ hybridization (ISH).
Results

Expression of Wnt genes in the adult intestine.
In order to provide a comprehensive expression profile of Wnt signaling components in the intestinal mucosa, we first collected and generated RNA probes for all murine Wnts (19 nes), sFRPs (5 genes), Dkks (4 genes Wnts were readily detected in the intestine {results are recapitulated in Figure 6 and igure 2. ISH analysis of Wnts expressed in ows at E18.5 Wnt-5a
Supplementary (Figure 1a) . Similarly, in the distal portion of the small intestine, Wnt-9b (also termed Wnt-14b) was found predominately at the bottom of the crypts (Figure 1b) . To confirm the identity of these cells, we performed immunostainings on consecutive 4µm sections for the classical Paneth cell marker, lysozyme. As shown on corresponding sections (Figure 1c and d) of the same intestinal crypt, Wnt-9b-expressing cells also produced lysozyme and thus represent Paneth cells. Interestingly, in more proximal areas of the small intestine Wnt-9b was also detected in epithelial progenitor cells above the Paneth cell compartment (Figure 1e ). Contrary to the small intestine, in the colon Wnt-9b was localized throughout the colonic epithelium (Figure 1f ). Moreover both Wnt-3 and 9b displayed weak expression in adenomas of APC min mice (data not shown). Note that a recent report has additionally observed Wnt-9b expression in the fetal gut (221). Finally, we found Wnt-6 expressed throughout the crypts of the small intestine and colon (Figure 1g and h). Similarly, Wnt-6 was strongly expressed in adenomas (Figure 1i ). Several Wnts were also found in specific compartments of the mesenchyme. In the fetal gut, Wnt-5a showed high expression at the tips of growing villi and in few discrete cells beneath the proliferative epithelium ( Figure 2a ). In the adult small intestine, Wnt-5a was similarly abundant in the villus tips, although weaker expression was also observed throughout the villi, as well as at the crypt-villus junction (Figure 2b ). In the colon, Wnt-5a and the closely related Wnt5b were restricted to the mesenchyme beneath the surface epithelium (Figure 2c and f). Lastly, Wnt-5a, and to a lesser extent Wnt-5b, were both upregulated in stromal cells of APC min polyps ( Figure 2d , 2e and data not shown). Unlike Wnt-5a, Wnt-4 was uniformly expressed along the villus mesenchyme and absent from adenomas ( Figure 2g and data not shown). However, in the colon Wnt-4 expression closely resembled Wnt-5a and 5b stainings (Figure 2h ). Finally, Wnt-2b was strongly expressed in the mesenchymal layer of the villi and more weakly in the crypts of the small intestine ( Figure 2i ). In the colon, Wnt-2b transcripts were less abundant and appeared to be markers of endothelial or smooth muscle cells (Figure 2j ). 
Expression of Wnt receptors in the adult intestine
cells, we next examined the expression of In order to identify putative Wnt-responsive Frizzled related receptors 1-10.
As indicated in Supplementary Table I (see  http: //www.niob.knaw.nl/researchpages/clevers/files) and Figure 3 , several Fz genes were located in both the fetal and adult intestine. As shown in Figure 3a and in van Es et al. (57), Fz-5 was detected in epithelial cells of the intervillus pockets of fetal guts and in the crypts of adult intestines. In addition, Fz-7 and Fz-4 were dynamically expressed during intestinal development. Fz-7 was strongly expressed in the smooth muscle layer and in inter-villus epithelial cells of neonates (P1) (data not shown); although at later stages, Fz-7 was confined to the epithelium of the crypt bottom (Figure 3b and c) . Fz-4 transcripts were also widely distributed in neonatal guts (Supplementary Table I ), while expression in adults was comparatively weaker and restricted to differentiated epithelial cells of the villi (Figure 3d ). One notable exception to this was the high levels of Fz-4 in adenomas, as shown in Figure 3e . Finally, Fz-6 was uniformly expressed throughout the epithelium of the small and large intestine (Figures 3f and g ). We also tested the expression of LRP co-receptors, LRP-5 and 6, given their absolute requirement in driving canonical Wnt signals. As expected we found both LRP-5 and 6 expressed in proliferative epithelial cells of the crypts (Figure 3h and data not shown). 
Expression of secreted Wnt antagonists in the adult intestine
The functional counterparts of the Fz receptors includ do , which allows sFRPs to compete with Fzs and thereby antagonize Wnt signaling. Of the five sFRP probes tested here, we only detected expression of sFRP-1 and 5. In the small intestine and colon, mesenchymal cells immediately adjacent to the crypts, as well as cells within the submucosa expressed abundant levels of sFRP-1 (Figure 4a , b and data not shown). sFRP-5 was strongly expressed in epithelial progenitor cells at E16.5 (Figure 4c ). However, in the mature intestine not all proliferative cells expressed sFRP-5. Indeed, sFRP-5 transcripts were detected in single cells in positions within the intestinal and colonic crypts reminiscent of stem cells (Figure 4d and e) (64;223;224). In some instances we also found weaker sFRP-5 expression throughout the crypt bottom of the small intestine (data not shown). To further define the localization of sFRP-5-expressing cells within the crypts, double stainings were performed for both sFRP-5 and Lysozyme {Supplementary Figure  2c (http://www.niob.knaw.nl/researchpages/clevers/files)}. This approach showed that cells expre sFRP-5 were located immediately above the Paneth cell compartment. We were also interested in comparing the expression of sFRP-5 with that of the proposed intestinal stem cell marker Musashi-1 (225-227). To test this we examined both sFRP-5 and Musashi-1 expression by in situ hybridization on consecutive sections. As shown in Supplementary Figure 2a and b, we found that sFRP-5 displayed a more localized expression pattern than Musashi-1. Indeed, we observed the latter was expressed throughout the epithelial progenitor cell compartment. Lastly, it is worth noting that sFRP-1 and sFRP-5 were not detected in intestinal polyps (data not shown). Figure 4f we found WIF uniquely expressed in adenomas, confirming a recent report (228). Similarly, a Dkk-2 probe specifically stained adenomas (Figure 4g ), whereas Dkk-3 was weakly expressed in the villus mesenchyme, myenteric plexi, and upregulated in adenomas (Figure 4h and i) . Dkk-1, Dkk-4 and Cerberus were undetected in the intestinal tract (data not shown).
E
Numerous studies have examined the function (38). As shown in Figure 5a and b, a TCF-4 probe revealed staining along the entire crypt-villus axis, as well as in the enteric nervous system. TCF-4 expression was also maintained in adenomas (data not shown). In the colon, TCF-4 transcripts were most abundant in differentiated cells of the surface epithelium, whereas expression diminished in the lower half of the crypts. Because a role for TCF-4 in non-proliferative cells was not anticipated based on the available genetic data (66), we wished to confirm the ISH results with TCF-4 antibody stainings. When comparing equivalent regions within the colon (see panels 5c and d), we once again found TCF-4 expressed predominately in non-cycling cells away from the crypt bottom.
is TCF-1. Indeed, APC min mice crossed into a TCF-1 null background display increased numbers of intestinal polyps, implying that TCF-1 acts downstream of TCF-4/β-catenin and may play a role in cancerogenesis (145). In agreement with this, we found TCF-1 expression strongly upregulated in adenomas when compared to normal proliferative crypt cells (Figure 5g ). However, we also observed TCF-1 transcripts in infiltrating gut lymphocytes, gut-associated lymphoid tissue (GALT) and Peyer's patches (Figure 5e and f). This result is supported by previous findings showing a crucial role for TCF-1 in thymocyte development (187). As with TCF-1, we also detected LEF expression in intestinal polyps, although in normal epithelium, LEF transcripts were absent (Figure 5h ). Similar findings were observed in human colorectal tumours, in which case LEF expression is directly regulated by TCF-4/β-catenin (146). Lastly, we also examined expression of TCF-3. Northern blot analysis has shown that TCF-3 is mainly expressed in the caudal portion of the intestinal tract (195) . Likewise, our analysis revealed expression of TCF-3 in proliferative compartment of the colon, although we were unable to detect TCF-3 elsewhere (Figure 5i ).
Discussion
In this paper we present an exhaustive overview of the expression pattern of Wnt signaling components in the murine intestine. As summarized in Figure 6 and Supplementary Table I (http://www.niob.knaw.nl/researchpages/clevers/files), Wnts and their downstream effectors are confined to specific mesenchymal and epithelial compartments of the intestine. Given these observations the function of at least some of these factors may be inferred. 
Canonical and non-canonical Wnt signaling in the gut
In Figure 1 we have shown that in the small intestine Wnt-3 and Wnt-9b are expressed in Paneth cells. In Paneth cells nuclear β-Catenin is readily detected and is thought to activate expression of the repulsion/guidance receptor EphB3 (86). EphB3 in combination with its ligand ephrin B1 force Paneth cells to occupy the very bottom of the crypts. Therefore, based on this evidence, Wnt-3 and Wnt-9b may act in an autocrine loop to activate TCF/β-catenin target genes involved in positioning of Paneth cells within the crypt-villus axis. Wnt-3 and Wnt-9b may also be important in promoting maturation of Paneth cells. We and others have recently shown that expression of Paneth cell markers, such as anti-microbial peptides (i.e. cryptdins and defensins), is dependent on active Wnt/β-catenin signals (102;103).
Alternatively, Wnt-3 and 9b, as well as Wnt-6 expressed in crypt cells, may signal to epithelial progenitor cells lying above Paneth cells. In turn, these canonical Wnts would drive proliferation, possibly through receptors identified here, such as Fz-5, Fz-7, and LRPs (Figure 3 ).
Along the same lines, recent immunohistological studies and in vitro functional assays have identified Wnt-11 as another candidate implicated in promoting proliferation (229).
Contrary to the Wnts discussed above, our study has also identified candidate Wnts likely involved in inducing non-canonical signals such as Wnt-2b, Wnt-4, Wnt-5a and Wnt5b. These Wnts are expressed in the villus mesenchyme in the small intestine and/or the mesenchyme adjacent to the surface epithelium in the colon (Figure 2) . In these regions, epithelial and mesenchymal cells are devoid of nuclear β-catenin and TCF target genes are turned off, implying that the above Wnts do not activate β-catenin/Tcf in the intestine (230). Several lines of evidence suggest that non-canonical Wnt signals regulate a complex array of cellular responses including increased calcium flux, repression of TCF-mediated transcription and cytoskeletal rearrangements (25;211). Therefore, in the intestine Wnt-2b, Wnt-4, Wnt-5a, Wnt-5b could conceivably inhibit proliferation and promote differentiation of epithelial cells, induce cellular polarity and promote villus formation. The expression pattern of Wnt-5a in the gut combined with recent functional analysis illustrates this point particularly well. Indeed, experiments in transfected cells and Wnt-5a deficient limb buds have shown that Wnt-5a promotes degradation of β-catenin and suppresses TCF-activated genes (231). In the fetal gut and adenomas, Wnt-5a is expressed in mesenchymal cells closely associated with highly proliferative epithelial cells. Thus in this context, Wnt-5a may function to down-regulate β-catenin and in turn attenuate proliferation.
The actions of non-canonical Wnts discussed above may be mediated by Fz-4 and Fz-6. Indeed, both receptors are expressed in the differentiated epithelial cells of the villi, in close proximity to Wnt-2b, Wnt-4, Wnt-5a and Wnt-5b-producing cells (Figure 3) . Similarly in adenomas, Fz-4 and Wnt-5a are upregulated in epithelial and stromal cells, respectively. Considering that Fz-4 is known to physically interact with Wnt-5a (32), these factors may coordinate cross-talk between epithelial and mesenchymal cells. Finally, functional and biochemical evidence suggest that Fz-6 is an important mediator of planar cell polarity signals in mammalian epithelial cells (232) and can actively repress canonical Wnt signals (233).
Factors modulating Wnt signaling in the intestine
Wnt signaling in self-renewing tissues such as the intestine is likely to be tightly regulated. Our screen of secreted Wnt antagonists has identified several factors, which may fulfill this function. sFRP-1, for example, was localized to the crypt mesenchyme, co-expressed and adjacent to cells abundantly expressing Wnts (Figure 4) . Consequently, sFRP-1 may function to modulate the effects of Wnt signaling in these regions. Indeed, a recent survey revealed that sFRP-1 was frequently downregulated in colorectal cancers, implying a tumour suppressor role for this factor (151). Moreover, forced expression of sFRPs block proliferation of colorectal cell lines (234). Similarly, WIF, as well as Dkk-2 and Dkk-3 may also play a role in tumorigenesis based on their ectopic expression in adenomas (Figure 4) . However, how these factors may be implicated in adenoma formation is unclear, given that Wnt signaling is constitutively turned on in these cells. Further complicating the matter, in vivo data has shown that Dkk-3 is unable to block Wnt signaling (235;236); whereas Dkk-2 can synergize with Fz receptors to induce Wnt signaling responses (237;238). Finally, sFRP-5 was strongly expressed in single epithelial cells of the bottom of crypts (Figure 4 and Supplementary Figure 2) . Labeling experiments have shown that stems cells, the number of which may vary from 1-6 per crypt are located in equivalent positions just above the Paneth cells in the small intestine and at the crypt base in the colon (64;223;224). We are presently investigating whether sFRP-5 positive cells represent bonefide stem cells by gene deletion in the mouse germ line.
Diverse functions for TCFs in the gut
In this manuscript we have identified several, previously unknown, sites within the intestinal mucosa harboring TCF family members. TCF-1, for example, is proposed to function as a tumour suppressor regulating proliferation of epithelial cells in the intestine (145). This is confirmed by our ISH data, which also point to a possible role for TCF-1 in gut lymphocytes. Similarly, the expression of TCF-4 in cellular compartments other than epithelial progenitors, such as the enteric nervous system and mature enterocytes ( Figure 5 ), suggests a broader role for TCF-4 in the gut. This notion is particularly evident in the colon where TCF-4 was found mainly in differentiated cell types. In several systems TCF transcription factors are known to both activate and repress transcription (239). Accordingly TCF-4, in differentiated, β-catenin inactive cells, may be required to suppress target genes associated with proliferation. On the other hand, Tcf-4 is also likely to play a role in maintaining proliferation of colonocytes. This assertion is based on the observation that in Tcf-4 -/-embryos proliferative epithelial cells are absent in the proximal portion of the colon (data not shown). The detection of TCF-3 in the colon in an inverse gradient to that of TCF-4, also poses an interesting question. Given the genetic data showing that TCF-3 primarily functions as a transcriptional repressor (179), it will be interesting to ascertain the role of TCF-3 in relation to TCF-4 in the colon.
In conclusion, our comprehensive overview of Wnt signaling in the intestine has identified for the first time specific Wnts and downstream signaling components likely involved in controlling both canonical and non-canonical pathways. In turn, this study reveals a broad role for Wnt signaling in regulating multiple aspects of intestinal development, homeostasis and cancerogenesis.
Material and Methods
-Probes
The following probes utilized in this study were described elsewhere. Wnt-1 (86;180); Wnt-2, 242); 243); ; Dkk-1 (247), Lef (194 
, TCF-1 (BF141520) and TCF-3 (AA015280). To insure the specificity of the probes we generated both sense and anti-sense probes for Wnt5b, WIF, and tested these in parallel in our in situ hybridization protocol. Representative examples are shown in Supplementary Figure 1 (see http://www.niob.knaw.nl/researchpages/clevers/files).
-In situ hybridization
Intestines from normal or APC min mice (C57Bl6, 3 months of age) were flushed and fixed overnight in Formalin. Samples were then dehydrated and embedded in paraffin, sectioned at 8µM and processed for hybridization as described below. Sections were dewaxed, rehydrated, treated with 0.2N HCL, digested in proteinase K solution, post-fixed, treated in acetic anhydride solution and hybridized overnight for 24-48hrs at 68°C with various probes in 5X SSC (pH 4.5), 50% Formamide, 2% Blocking Powder (Roche), 5mM EDTA, 50µg/ml yeast tRNA, 0.1% Tween 20, 0.05%CHAPS and 50µg/ml Heparin. Sections were then rinsed in 2X SSC and washed for 3X 20minutes at either 60 or 65°C in 2X SSC/50% Formamide. Following several rinses in TBST, sections were then blocked for 1/2 hour in TBST containing 0.5% Blocking Powder (Roche). Next, sections were incubated in blocking solution overnight at 4°C with alkaline phosphatase-conjugated anti-digoxigenin (1/2000 dilution) (Roche). After washing several times in TBST, the color reaction was performed with NBT/BCIP solution. For image analysis, sections were temporally mounted in glycerol or permanently mounted after dehydration in Pertex. A complete protocol will be provided upon request. In vitro transcription reactions to generate labeled probe was performed as follows: 1µg of linearized DNA was incubated at 37°C for more than 2 hours with 4 µl transcription buffer (Promega), 2 µl of DTT 0.1M (Promega), 2 µl of Dig RNA labeling mix (Roche), 1 µl RNAse inhibitor (Promega) and 1.5 µl of T7 or T3 or SP6 (Promega) in a total volume of 20 µl.
-Antibody staining Immunohistochemistry procedure is described elsewhere (86). Briefly, sections were pretreated with peroxidase blocking buffer (120 mM Na 2 HPO 4 , 43 mM citric acid, 30 mM NaN 3 , 0.2% H 2 O 2 ; pH 5.8) for 20 minutes at room temperature. Antigen retrieval was performed by boiling samples in Na-citrate buffer (10 mM, pH 6.0). After 20 minutes, the boiling pan was allowed to slowly cool down to room temperature. Incubation of antibodies was performed in 1% BSA in PBS overnight at 4°C. The primary antibodies used in this study were rabbit anti-lysozyme (1:500; DAKO) and goat anti-TCF-4 (1:500; Santa Cruz). Rabbit anti-goat (DAKO) and rabbit EnVision+ (DAKO) were used as secondary antibodies.
